Compound Summary
GYKI 52895
Compound Information
GYKI 52895
Compound Name: | GYKI 52895 |
Compound CID: | 3539 |
Synonyms: | GYKI 52895 114460-08-1 4-(8-Methyl-8,9-dihydro-7H-1,3dioxolo4,5:4,5benzo1,2-d1,2diazepin-5-yl)aniline GYKI-52895 1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine More... |
Iupac Name: | 4-(8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline |
InChI: | InChI=1S/C17H17N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8,10,19H,6,9,18H2,1H3 |
InChIKey: | AQTITSBNGSVQNZ-UHFFFAOYSA-N |
Canonical Smiles: | CC1CC2=CC3=C(C=C2C(=NN1)C4=CC=C(C=C4)N)OCO3 |
Isomeric Smiles: | CC1CC2=CC3=C(C=C2C(=NN1)C4=CC=C(C=C4)N)OCO3 |
Molecular Weight: | 295.34 |
Molecular Formula: | C17H17N3O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
GYKI 52895
Molecular Weight: | 295.34 |
Molecular Formula: | C17H17N3O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 22 |
Complexity: | 434 |
Synonyms
GYKI 52895
| GYKI 52895 | GYKI 52895 |
|---|---|
GYKI 52895 |
114460-08-1 |
4-(8-Methyl-8,9-dihydro-7H-1,3dioxolo4,5:4,5benzo1,2-d1,2diazepin-5-yl)aniline |
GYKI-52895 |
1-(4-Aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine |
CHEBI:79613 |
4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine |
4-(8-methyl-8,9-dihydro-7h-1,3dioxolo4,5-h2,3benzodiazepin-5-yl)aniline |
7H-1,3-Dioxolo4,5-h2,3benzodiazepine, benzenamine deriv. |
1-(4-AMINOPHENYL)-4-METHYL-7,8-METHYLENEDIOXY-3.4-DIHYDRO-5H-2,3-BENZODIAZEPINE |
4-(8,9-Dihydro-8-methyl-7H-1,3-dioxolo4,5-h2,3benzodiazepin-5-yl)benzenamine |
GYKI 52895, solid |
Benzenamine, 4-(8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)- |
Lopac0_000562 |
SCHEMBL6995439 |
CHEMBL1256984 |
GYKI52895 |
DTXSID80921385 |
2387AA |
1-(4-Aminophenyl)-4-methyl-7,8- |
CCG-204652 |
NCGC00015464-02 |
NCGC00015464-03 |
NCGC00093947-01 |
NCGC00093947-02 |
EU-0100562 |
SR-01000075406 |
Q5515085 |
SR-01000075406-1 |
methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine hydrochloride |
1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3benzodiazepine |
4-(8-Methyl-8,9-dihydro-2H,7H-1,3dioxolo4,5-h2,3benzodiazepin-5-yl)aniline |
869360-93-0 |
Experimental Data
GYKI 52895
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 7.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
GYKI 52895
Statistics Data
GYKI 52895
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 7.000000000000000 | 1 | 1 |
Statistics Data Visualization
GYKI 52895
